Effect of the menstrual cycle and oral contraceptives on cyclooxygenase-2 expression in the endometrium

Gynecological Endocrinology

Volumn 21, Issue 1, 2005, Pages 57-61

  Maia Jr , Hugo ^a   Maltez, Amélia ^a   Studard, Eduardo ^b   Zausner, Bela ^c   Athayde, Célia ^a   Coutinho, Elsimar ^a  

^a Centro De Pesquisa E Assistencia Em Reproducao Humana   (Brazil)

^b FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^c Genesis IVF Clinic   (Brazil)

Author keywords

COX 2; Gestodene; Ki 67; Menstruation; Prostaglandins

Indexed keywords

CYCLOOXYGENASE 2; GESTINOL; GESTODENE; KI 67 ANTIGEN; ORAL CONTRACEPTIVE AGENT;

ADULT; ARTICLE; BLEEDING; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; DYSMENORRHEA; ENDOMETRIUM; ENDOMETRIUM BIOPSY; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LUTEAL PHASE; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; ORAL CONTRACEPTION; OVULATION; PREMENOPAUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; CONTRACEPTIVES, ORAL; CYCLOOXYGENASE 2; ENDOMETRIUM; EPITHELIUM; FEMALE; HUMANS; KI-67 ANTIGEN; LUTEAL PHASE; MENSTRUAL CYCLE; MIDDLE AGED; PREMENOPAUSE;

EID: 23244439952     PISSN: 09513590     EISSN: None     Source Type: Journal    
DOI: 10.1080/09513590500099602     Document Type: Article

References (21)

1. Appleby SB, Ristimaki A, Neilson K. Structure of the human cyclooxygenase-2 gene. Biochem J 1994;302:723-27.
2. Smith WL, DeWitt DL, Garavito RM. Cyclooxygenases: structural, cellular and molecular biology. Annu Rev Biochem 2000;69:145-82.
3. Ota H, Igarashi S, Sasaki M, Tanaka T. Distribution of cyclooxygenase-2 in eutopic and ectopic endometrium in endometriosis and adenomyosis. Hum Reprod 2001;16:561-6.
4. Capdevila C. Dysfunctional uterine bleeding and dysmenorrhea. Eur J Contracept Reprod Health Care 1997;2:229-37.
5. Rees MC, Anderson AB, Demers LM, Turnbull AC. Prostaglandins in menstrual fluid in menorrhagia and dysmenorrhea. Br J Obstet Gynaecol 1984;91:673-80.
6. Hayes EC, Rock JA. Cox-2 inhibitors and their role in gynecology. Obstet Gynecol Surv 2002;57:768-80.
7. Brill K, Schnitker J, Albring M. Long term experience with a low dose oral contraceptive. Gynecol Endocrinol 1990;4:277-286.
8. Hsu SC, Long CY, Yang CH, Wu CH, Chen CH, Liu FI. Cyclooxygenase expression in the endometrium at the end of 2 years continuous combined hormone replacement therapy. Maturitas 2003;46:295-9.
9. Brill K, Norpoth S, Schnitker J, Albring M. Clinical experience with a modern low-dose oral contraceptive in almost 100,000 users. Contraception 1991;43:101-10.
10. Uotila PJ, Erkkola RU, Klemi PJ. The expression of cyclooxygenase 1 and 2 in proliferative endometrium and endometrial adenocarcinoma. Ann Med 2002;34:428-33.
11. Lumsden MA, Kelly RW, Abel MH, Baird DT. The concentration of prostaglandins in endometrium during the menstrual cycle in women with measured menstrual blood loss. Prostaglandins Leukot Med 1986;23:217-27.
12. Sun T, Diao HL, Teng CB, Wang HB, Yang ZM. Cyclooxygenases and prostaglandin E synthases in the endometrium of the rhesus monkey during the menstrual cycle. Reproduction 2004;127:465-73.
13. Marions L, Gemzell Danielsson K. Expression of cyclooxygenase in human endometrium during the implantation period. Mol Hum Reprod 1999;5:961-5.
14. Morrison BW, Daniels SE, Kotey P, Cantun N, Seidenberg M. Rofecoxib, a specific cyclooxygenase-2 inhibitor in primary dysmenorrhea: a randomized controlled trial. Obst Gynecol 1999;94:504-8.
15. Bielgmayer C, Hofer G, Kainz C, Reuinthaller A, Kopp B, Janisch H. Concentration of various arachidonic acid metabolites in menstrual fluid are associated with menstrual pain and are influenced by hormonal contraceptives. Gynecol Endrocrinol 1995;9:307-12.
16. Nigam S, Benedetto C, Zonca M, Leo-Rossberg I, Lubbert H, Hammerstein J. Increased concentration of eicosanoids and platelet-activating factor in menstrual blood from women with primary dysmenorrhea. Eicosanoids 1991;4:137-41.
17. Bielgmayer C, Hofer G, Reinthaller A, Janisch H. Effect of hormonal contraceptives on eicosanoid content of menstrual blood. Gynakol Rundsch 1991;31(Suppl 2):375-7.
18. Sales KJ, Jabbour HN. Cyclooxygenase enzymes and prostaglandins in pathology of endometrium. Reproduction 2003;126:559-67.
19. Critchley HOD, Jones RL, Lea R, Drudy TA, Kelly RW, Baird DT. Role of inflammatory mediators in human endometrium during progesterone withdrawal and early pregnancy. J. Clin Endocrinol Metab 1999;84:240-8.
20. Kelly RW, Smith SK. Progesterone and anti progestins. A comparison of their effects on prostaglandin production by human secretory phase endometrium and decidua. Prostaglandins Leukotr Med 1987;29:181-6.
21. Stavreus-Evers A, Koraen L, Scott JE, Zhang P, Westlund P. Distribution of cyclooxygenase-1, cyclooxygenase-2, and cytosolic phospholipase A2 in the luteal phase human endometrium and ovary. Fertil Steril 2005;83:156-62.